Please assess the completion status of the following clinical trial:

Trial Title: LifeVest Post-CABG Registry

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patients who have undergone CABG surgery during current hospitalization~* Patients who have an ejection fraction ≤ 35% following the surgery.~* Patients who have dilated cardiomyopathy or prior myocardial infarction.~* Patients who are prescribed a wearable defibrillator following surgery.~* Patient who are at least 18 years old.~Exclusion Criteria:~* Patients who have an active ICD.~* Patients who have an active unipolar pacemaker.~* Patients having a chest circumference over 56 inches or under 26 inches.~* Patients who are unable to consent or unwilling to wear the WCD after discharge or who do not agree to be contacted at 90 days.~* Patients with a mental, visual, physical or auditory deficit that could impair their ability to properly interact with a wearable defibrillator.~* Patients participating in another clinical study with mortality as the primary endpoint.~* Patients unable to use a wearable defibrillator due to physical conditions (bandages preventing electrode contact, physical deformities preventing electrode contact, dextrocardia, etc.).~* Patients who have decided to forgo resuscitation.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- wearable defibrillator use (Type: None): subjects will use a wearable defibrillator

Based on this trial design, predict the completion outcome and termination type (if applicable).